SILDI-SAFE: Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary
What is the safety and preliminary effectiveness of sildenafil in premature infants
with severe Bronchopulmonary Dysplasia (BPD)?
Basic Study Information
Purpose:Location: University of Rochester School of Medicine Children's Hospital
This is a multicenter study of sildenafil in premature infants in Neonatal Intensive
Care Units (NICUs) with severe bronchopulmonary dysplasia (BPD). Infants must be receiving
respiratory support at enrollment.
Study Reference #: STUDY00006543
Lead Researcher (Principal Investigator)
Study Contact InformationStudy Coordinator: Elizabeth Carbonell, MPH, CCRC
Phone: (585) 273-2322
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search